Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT01689246

Public ClinicalTrials.gov record NCT01689246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of TRx0237 in the treatment of subjects with mild to moderate Alzheimer's Disease.

Study identification

NCT ID
NCT01689246
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
TauRx Therapeutics Ltd
Industry
Enrollment
891 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2013 (Type not available)
Primary completion
Nov 2015 (Actual)
Completion
Nov 2015 (Actual)
Last update posted
Mar 14, 2018

2013 – 2015

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Xenoscience, Inc/ 21st Century Neurology Phoenix Arizona 85004 —
Feldman, Robert MD Laguna Hills California 92653 —
University of Southern California Los Angeles California 90033 —
Shankle Clinic and Hoag Memorial Hospital Presbyterian Newport Beach California 92658 —
Pacific Research Network San Diego California 92103 —
San Francisco Clinical Research Center San Francisco California 94118 —
Yale University School of Medicine New Haven Connecticut 06510 —
JEM Research Atlantis Florida 33462 —
Brain Matters Research Delray Beach Florida 33445 —
CNS Healthcare, Inc Jacksonville Florida 32256 —
Compass Research, LLC-North Clinic Leesburg Florida 34748 —
Miami Research Associates Miami Florida 33143 —
Compass Research, LLC Orlando Florida 32806 —
iResearch Atlanta Decatur Georgia 30030 —
Alexian Brothers Neurosciences Institute Elk Grove Illinois 60007 —
ActivMed Practices & Research Methuen Massachusetts 01844 —
Olive Branch Family Medical Olive Branch Mississippi 38654 —
Memory Enhancement Centers of America, Inc Eatontown New Jersey 07724 —
CRI Worldwide Marlton New Jersey 08053 —
The Cognitive Research Center of New Jersey Springfield New Jersey 07801 —
Advanced Memory Research Institute of NJ PC Toms River New Jersey 08757 —
Neurological Associates of Albany, P. C. Albany New York 12208 —
SPRI Brooklyn New York 11235 —
Neurobehavioral Clinical Research Canton Ohio 44718 —
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046 —
FutureSearch Trials of Neurology Austin Texas 78731 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01689246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 14, 2018 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01689246 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →